Molecular Targeting Probes - Radioactive & Nonradioactive -> Preclinical Probes for Oncology 440

440 - PET imaging of 11C-labeled cyclooxygenase-1 (COX-1) and COX-2 radioligands in ovarian, breast, and pancreatic cancer xenograft mouse models. (ID 723)

Session Name
Preclinical Probes for Oncology II
Speakers
Authors
Presentation Topic
Molecular Targeting Probes - Radioactive & Nonradioactive -> Preclinical Probes for Oncology
Presentation Number
440

Previous Eposter
612 - Impact of a Gaussian filter applied to post-reconstruction PET on radiomic features in assessing tumor heterogeneity in breast cancer. (ID 1046)

Next Eposters
1470 - Deep learning-based correction of PET attenuation correction artifacts at the lung-liver interface (ID 190)
1305 - Clinical validation of data-driven PET respiratory gating: impact on image quality and lesion conspicuity (ID 399)
1410 - Automatic image classification using labels from radiology text reports: predicting Deauville scores (ID 1308)
1552 - Metabotropic glutamate receptor subtype 5 function in fragile X syndrome (ID 883)
1060 - Improving the Synthesis of48V labeled [VO(acac)2] andIn Vitro andIn VivoValidation (ID 756)
1222 - Using comparative oncology approach to develop radioimmunotherapy for osteosarcoma (ID 96)
455 - Early peak equilibrium is superior to late pseudo-equilibrium for simplified quantification of 18F-FE-PE2I PET (ID 862)
1516 - Evaluation of PET Image Quality Using Non-Conventional Isotopes (ID 1146)
936a - Selective imaging of matrix metalloproteinase-13 to detect extracellular matrix remodelling in atherosclerotic lesions (ID 1350)
1053 - Development of a 89Zr radiolabeled anti-CD33 antibody for PET imaging of Acute Myeloid Leukemia (ID 736)